Article

Applied Clinical Trials

Applied Clinical Trials

Applied Clinical Trials-09-01-2012
Volume21
Issue 9

Cover

S

Cover

Download Issue PDF
Articles in this issue
Bridging US and China to Conquer Cancer
Figure1-788581-1408597553236.jpg
Selection of Phase I Service Providers
We Still Love Paper
Flow Cytometry
Figure-788574-1408597572290.jpg
ePRO in Diabetes Studies
More Transparency, Standards Urged for Research

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!
Related Videos
Related Content
Eli Lilly’s Investigational Oral GLP-1 Receptor Agonist Demonstrates Significant Weight Loss
August 8th 2025

Eli Lilly’s Investigational Oral GLP-1 Receptor Agonist Demonstrates Significant Weight Loss

Don Tracy, Associate Editor
ACT Brief Episode 1: Placebos, Politics, and the Ethics of Vaccine Trials
August 8th 2025

ACT Brief Episode 1: Placebos, Politics, and the Ethics of Vaccine Trials

Applied Clinical Trials Editorial Staff
Credit: Lars Neumann | stock.adobe.com
August 8th 2025

FDA Supports Continued Development of Eftilagimod Alfa in PD-L1–Negative Head and Neck Cancer

Andy Studna, Senior Editor
Unifying Industry to Better Understand GCP Guidance
August 8th 2025

Unifying Industry to Better Understand GCP Guidance

Andy Studna, Senior Editor
MetaVia Expands GLP-1 Glucagon Receptor Agonist Obesity Trial Amid Signs of Superior Tolerability
August 8th 2025

MetaVia Expands GLP-1 Glucagon Receptor Agonist Obesity Trial Amid Signs of Superior Tolerability

Don Tracy, Associate Editor
Navigating Complexity: Strategies to Accelerate Modern Clinical Trials
August 8th 2025

Navigating Complexity: Strategies to Accelerate Modern Clinical Trials

Cindy Henderson
© 2025 MJH Life Sciences

All rights reserved.